Ning Li | Gene Regulations | Best Researcher Award

Dr. Ning Li | Gene Regulations | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Li Ning, Ph.D. 🧬

Lecturer, School of Disaster and Emergency Medicine, Faculty of Medicine

Research Areas :🧠

  • Molecular mechanisms of traumatic injury
  • Immunotherapy
  • Mechanobiology

📧 Email: lining620@tju.edu.cn

Brief Introduction:

Dr. Li Ning received her Ph.D. from Nankai University, China, in 2019. Since then, she has been a dedicated lecturer at Tianjin University, where she also supervises master's students. Her research delves into the pathogenic mechanisms of trauma, cell death in trauma-related diseases, immunotherapy, and biomechanics within disaster medicine. Dr. Ning has led numerous national, provincial, and university-level research projects, with her work published in esteemed journals like Nucleic Acids Research, Military Medical Research, Trends in Pharmacological Sciences, Cell Death & Discovery, and Pharmacological Research.

Educational Background 🎓

  • 2008.09 - 2012.07: Bachelor's in Bioscience and Biotechnology, Shenyang Agricultural University
  • 2012.09 - 2015.07: Master's in Medicine, Nankai University
  • 2015.09 - 2018.12: Ph.D. in Pharmacy, Nankai University

Professional Experience 💼

  • 2019.05 - Present: Lecturer, School of Disaster and Emergency Medicine, Faculty of Medicine, Tianjin University

Academic Achievements:

Dr. Li Ning has an impressive list of published research papers, several of which highlight her contributions to the understanding of cell death mechanisms and potential therapeutic targets for trauma management. Additionally, she holds multiple patents, including innovations in nucleic acid detection and crush injury modeling equipment.

Fellowships & Honors 🏆

  • Excellent Master's Thesis, Nankai University (2015)
  • Teaching and Educating Excellence Award, Tianjin University (2022)
  • Scientific Research Rookie Award, Tianjin University (2022)
  • Outstanding Mentor, Tianjin University (2023)
  • Multiple awards for outstanding contributions and excellence in teaching from Tianjin University (2022-2024)

Dr. Ning continues to contribute significantly to the fields of disaster and emergency medicine through her research and teaching.

Journal Publications 📚

  • Nucleic Acids Research
    • Li Ning might have contributed research on the molecular mechanisms of traumatic injury, possibly focusing on DNA damage and repair mechanisms or gene expression changes post-injury.
  • Military Medical Research
    • Research related to trauma, particularly in military settings, could include studies on immunotherapy and the impact of cell death on traumatic injuries, as well as advances in medical biomechanics.
  • Trends in Pharmacological Sciences
    • Likely publications could discuss cutting-edge approaches in immunotherapy or pharmacological interventions targeting trauma-induced pathogenesis.
  • Cell Death & Discovery
    • Studies on the role of cell death in trauma-related diseases, focusing on molecular pathways and therapeutic targets.
  • Pharmacological Research
    • Research papers could include findings on drug interventions for trauma-induced pathologies, including immunotherapeutic strategies and their mechanobiological implications.

Notable Publications 📑

"Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment" 

  • Authors: Qiao, O., Wang, X., Wang, Y., Li, N., Gong, Y.
  • Journal: Journal of Advanced Research
  • Year: 2023

"Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies" 

  • Authors: Li, N., Han, L., Wang, X., Zhang, L., Gong, Y.
  • Journal: Translational Research
  • Year: 2023

"Delayed step-by-step decompression with DSF alleviates skeletal muscle crush injury by inhibiting NLRP3/CASP-1/GSDMD pathway "

  • Authors: Li, N., Wang, X., Wang, Y., Fan, H., Gong, Y.
  • Journal: Cell Death Discovery
  • Year: 2023

"Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation"

  • Authors: Yu, J., Du, Y., Liu, C., Wang, Y., Qin, J.
  • Journal: Life Sciences
  • Year: 2024

"Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation"

  • Authors: Xie, Y., Shan, M., Yu, J., Lan, L., Wang, Y.
  • Journal: Cancer Science
  • Year: 2024